HomeCompareGKSDF vs PFE

GKSDF vs PFE: Dividend Comparison 2026

GKSDF yields 2.85% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GKSDF wins by $321.78M in total portfolio value
10 years
GKSDF
GKSDF
● Live price
2.85%
Share price
$1.90
Annual div
$0.05
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$321.83M
Annual income
$301,488,366.64
Full GKSDF calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — GKSDF vs PFE

📍 GKSDF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGKSDFPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GKSDF + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GKSDF pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GKSDF
Annual income on $10K today (after 15% tax)
$241.99/yr
After 10yr DRIP, annual income (after tax)
$256,265,111.64/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, GKSDF beats the other by $256,242,791.74/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GKSDF + PFE for your $10,000?

GKSDF: 50%PFE: 50%
100% PFE50/50100% GKSDF
Portfolio after 10yr
$160.94M
Annual income
$150,757,312.68/yr
Blended yield
93.67%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

GKSDF
No analyst data
Altman Z
1.9
Piotroski
8/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GKSDF buys
0
PFE buys
0
No recent congressional trades found for GKSDF or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGKSDFPFE
Forward yield2.85%6.13%
Annual dividend / share$0.05$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%13.2%
Portfolio after 10y$321.83M$49.6K
Annual income after 10y$301,488,366.64$26,258.71
Total dividends collected$320.31M$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: GKSDF vs PFE ($10,000, DRIP)

YearGKSDF PortfolioGKSDF Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$11,269$569.39$9,153$693.39+$2.1KGKSDF
2$13,258$1,199.39$8,593$849.25+$4.7KGKSDF
3$16,823$2,637.38$8,336$1,066.78+$8.5KGKSDF
4$24,256$6,255.43$8,437$1,384.80+$15.8KGKSDF
5$42,813$16,858.51$9,013$1,875.40+$33.8KGKSDF
6$101,427$55,618.03$10,306$2,680.72+$91.1KGKSDF
7$354,817$246,289.74$12,820$4,101.38+$342.0KGKSDF
8$1,990,083$1,610,429.07$17,673$6,826.70+$1.97MGKSDF
9$19,012,581$16,883,191.40$27,543$12,591.86+$18.99MGKSDF
10$321,831,828$301,488,366.64$49,560$26,258.71+$321.78MGKSDF

GKSDF vs PFE: Complete Analysis 2026

GKSDFStock

Grupo KUO, S.A.B. de C.V., through its subsidiaries, manufactures and sells consumer business products, plastics, chemical products, and auto parts in Mexico, the United States, Spain, Belgium, and China. It operates through three segments: Consumer, Chemical, and Automotive. The Consumer segment primarily engages in the production and sale of pork meat; and consumer products, including processed food and beverages. The Chemical segment is involved in the manufacture and sale of plastics and chemical products, such as synthetic rubber and polymers. The Automotive segment engages in the manufacture and assembly of high-performance components and transmissions; and produces and markets automotive parts, such as pistons, brakes, bearings, gaskets, and seals primarily under the Tremec, Fritec, TF Victor, and Moresa brands. The company was formerly known as DESC, S.A.B. de C.V. and changed its name to Grupo KUO, S.A.B. de C.V. in March 2007. Grupo KUO, S.A.B. de C.V. was incorporated in 1973 and is headquartered in Mexico City, Mexico.

Full GKSDF Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this GKSDF vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GKSDF vs SCHDGKSDF vs JEPIGKSDF vs OGKSDF vs KOGKSDF vs MAINGKSDF vs JNJGKSDF vs MRKGKSDF vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.